SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-19-002211
Filing Date
2019-02-12
Accepted
2019-02-12 15:05:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G sc13g1218a1nineteen_orexigen.htm SC 13G/A 48875
  Complete submission text file 0001213900-19-002211.txt   50501
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Subject) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-83422 | Film No.: 19590178
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 NORTH WACKER CHICAGO IL 60606
Business Address 1 NORTH WACKER CHICAGO IL 60606 312-525-6064
Nineteen77 Global Multi-Strategy Alpha Master Ltd (Filed by) CIK: 0001698095 (see all company filings)

IRS No.: 980227879 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A